Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Trials|September 18, 2020
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trialElizabeth C James, David Dunn, Adrian D Cook, et al.
JNCI Cancer Spectrum|June 30, 2020
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)Olivier Colomban, Michel Tod, Julien Peron, et al.
AIDS (London, England)|April 14, 2011
Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapyAndrew Prendergast, Mutsa F Bwakura-Dangarembizi, Adrian D Cook, et al.
AIDS (London, England)|April 23, 2019
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and ZimbabweAndrew J Prendergast, Chipo Berejena, Godfrey Pimundu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.
European Urology|August 31, 2024
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
The Lancet. Oncology|July 3, 2020
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trialSarah P Blagden, Adrian D Cook, Christopher Poole, et al.
The Lancet. Oncology|December 28, 2020
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trialRobert D Morgan, Iain A McNeish, Adrian D Cook, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
Pageof 2